Study of Patients With ITP Estimating the Proportion Administering Romiplostim Correctly After Receiving Home Administration Training

Clinical trial NCT02085993 · COMPLETED

Trial details

NCT number: NCT02085993
Sponsor: Amgen
Status: COMPLETED
Study type: OBSERVATIONAL

Immune Thrombocytopenic Purpura

Start date: 2014-07-01
Primary completion: 2015-11-01
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.